Shandong Xinhua Pharmaceutical Company Limited

HK$5.47As of Sun 8 Nov 2026, 12:00 UTC
HKEX:0719Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 5.51%
Div yield 3.20%
ROE 4.25%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.02)
PE TTM 14.18
TSR TTM (18.86%)
Mkt cap HK$8.506B
ROIC 4.39%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.87
7.17%
(84.80%)
Hold 7|6|11|2|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.07
0.07
0.08
20.40%
21.33%
22.30%
35.83%
Revenue¥M
535.3
552.6
577.9
581.3
13.71%
12.17%
15.23%
12.83%
Peers (US$1.085B)
Cap (US$)
PE
1.094B
—
1.080B
22.72x
1.079B
48.36x
Capital
TTM
5Y
10Y
Leveragex
0.826
2.053
1.666
EBIT/Intx
1.745
1.597
1.524
Own earn%
(141.58)
143.30
140.27
Sh yield%
32.67
51.45
53.59
Owners
Insiders/Inst%
3.80
70.86
Short interest%
3.46
SBC / revenue%
5.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
3–10
$1 testx
0.2
Incr. ROIC%
5